PharmaCorp Enters Letter of Intent for the Acquisition of Pharmacy Files in Western Canada

About this update from Pharmacorp Rx Inc.

[{"type":"text","content":"PharmaCorp Enters Letter of Intent for the Acquisition of Pharmacy Files in Western Canada\n\n\n\n SASKATOON, Saskatchewan, Dec. 11, 2025 (GLOBE NEWSWIRE) --\n \n PHARMACORP RX INC.\n \n (“\n \n PharmaCorp\n \n ” or the “\n \n Corporation\n \n ”) (TSXV: PCRX) is pleased to announce that it has entered into a non-binding letter of intent (“\n \n LOI\n \n ”) to acquire from an arm’s length vendor (the “\n \n Vendor\n \n ”) the prescription files, patient records, and related operational data (the “\n \n Pharmacy\n \n\n Files\n \n ”) of a pharmacy located in the same community as one of PharmaCorp’s existing PharmaChoice-bannered pharmacies in Western Canada (the “\n \n Proposed Acquisition\n \n ”). The purchase price for the Proposed Acquisition is anticipated to be $350,000 subject to customary adjustments. The Proposed Acquisition will be satisfied with cash on hand with closing expected to occur during the first quarter of 2026. No finder’s fees are payable in respect of the Proposed Acquisition.\n \n\n The Proposed Acquisition does not involve the purchase of the target’s corporate entity, fixtures, or other operating assets. Following completion, all patient files are expected to be transferred to, and serviced by, PharmaCorp’s existing pharmacy in the community.\n \n\n Completion of the Proposed Acquisition is subject to the execution of a definitive agreement which will include the final agreed upon terms and conditions of the Proposed Acquisition, including such terms, ‎representations, warranties, indemnities and covenants as ‎are customary in transactions similar to the ‎Proposed Acquisition, and the satisfaction of customary conditions, including satisfactory due diligence. There can be no assurance that the Proposed Acquisition will be completed as proposed, or at all.\n \n\n “This transaction reflects our disciplined approach to growth and our commitment to strengthening patient care in the communities we serve,” said Alan Simpson, Executive Chair of the Board of PharmaCorp. “By integrating these Pharmacy Files into our existing pharmacy, we can enhance operational efficiency while ensuring continuity of care for local residents.”\n \n\n PharmaCorp cont...

More updates from Pharmacorp Rx Inc.